OncoMethylome
Europe, Liege, Belgium, Liège
Description
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer.
Investor Profile
OncoMethylome has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B rounds (top funding stages).
- Majority of deals are located in Germany.
- Strong thematic focus on Biotechnology, Health Care, Oncology.
Stage Focus
- Series C (50%)
- Series B (50%)
Country Focus
- Germany (100%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does OncoMethylome frequently co-invest with?
What are some of recent deals done by OncoMethylome?
Find More Investors Like OncoMethylome
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
